BACKGROUND: @entity3619 is characterized by the accumulation of lymphocytes as a consequence of increased recruitment from the blood and retention within the tissue at sites of @entity281 . @entity31229 ( @entity31229 ) mRNA has been detected in both inflamed and normal liver tissues and is strongly upregulated in the injured liver tissues in a @entity19 model. The aim of this study was to investigate the effect of @entity28015 on @entity31229 mRNA of liver tissues in @entity19 with immunological @entity99 . METHODS: The @entity19 model of immunological @entity99 was induced by Bacillus Calmette Guerin and Lipoposaccharide. The @entity19 with immunological @entity99 were randomly assigned to the model group, the @entity28015 group and the @entity2756 group. The three groups were continuously given agents for seven days and @entity31229 mRNA of liver tissue was determined and contrasted with the control group treated by normal saline. Reverse transcription-polymerase chain reaction was used to assay @entity31229 mRNA levels in liver tissues. RESULTS: The expressions of @entity31229 mRNA were significantly higher in the model group and the @entity2756 group than in the control group and the @entity28015 group (P < 0.05), indicating the @entity19 in the model group and the @entity2756 group were @entity465 . There was no statistical difference in the expressions of @entity31229 mRNA between the control group and the @entity28015 group. Similarly, no statistical difference in the expressions of @entity31229 mRNA between the model group and the @entity2756 group was detected (P > 0.05). CONCLUSION: @entity28015 effectively reduces the infiltration of lymphocytes into liver tissues and alleviates the @entity409 by decreasing @entity31229 mRNA in liver tissues in @entity19 with immunological @entity99 .

Effects of @entity28015 on chemokines of liver tissues in @entity19 with immunological XXXX .

@entity31229 :: ('66102(Tax:10090)', 'Gene') :: ['CXC chemokine ligand 16', 'CXCL16'] @entity2756 :: ('MESH:D002443', 'Chemical') :: ['ceftriaxone'] @entity28015 :: ('MESH:C033356', 'Chemical') :: ['Cefodizime', 'cefodizime'] @entity19 :: ('10090', 'Species') :: ['mice', 'murine'] @entity409 :: ('MESH:D008107', 'Disease') :: ['liver damage'] @entity281 :: ('MESH:D007239', 'Disease') :: ['infection'] @entity465 :: ('MESH:D007153', 'Disease') :: ['immunodeficient'] @entity3619 :: ('MESH:D006521', 'Disease') :: ['Chronic hepatic inflammation'] @entity99 :: ('MESH:D056486', 'Disease') :: ['hepatic injury']
@entity99 :: (MESH:D056486,Disease) :: ['hepatic injury']
